rs151027707

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002972.4(SBF1):​c.2127+4C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00248 in 1,609,502 control chromosomes in the GnomAD database, including 59 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 29 hom., cov: 33)
Exomes 𝑓: 0.0017 ( 30 hom. )

Consequence

SBF1
NM_002972.4 splice_region, intron

Scores

2
Splicing: ADA: 0.004438
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -3.07

Publications

0 publications found
Variant links:
Genes affected
SBF1 (HGNC:10542): (SET binding factor 1) This gene encodes a member of the protein-tyrosine phosphatase family. However, the encoded protein does not appear to be a catalytically active phosphatase because it lacks several amino acids in the catalytic pocket. This protein contains a Guanine nucleotide exchange factor (GEF) domain which is necessary for its role in growth and differentiation. Mutations in this gene have been associated with Charcot-Marie-Tooth disease 4B3. Pseudogenes of this gene have been defined on chromosomes 1 and 8. [provided by RefSeq, Dec 2014]
SBF1 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease type 4B3
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 22-50462555-G-A is Benign according to our data. Variant chr22-50462555-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 235427.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0101 (1538/152264) while in subpopulation AFR AF = 0.0326 (1356/41556). AF 95% confidence interval is 0.0312. There are 29 homozygotes in GnomAd4. There are 734 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 29 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SBF1NM_002972.4 linkc.2127+4C>T splice_region_variant, intron_variant Intron 18 of 40 ENST00000380817.8 NP_002963.2 O95248-5
SBF1NM_001410794.1 linkc.2130+4C>T splice_region_variant, intron_variant Intron 18 of 40 NP_001397723.1
SBF1NM_001365819.1 linkc.2130+4C>T splice_region_variant, intron_variant Intron 18 of 39 NP_001352748.1
SBF1NM_001410795.1 linkc.2127+4C>T splice_region_variant, intron_variant Intron 18 of 39 NP_001397724.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SBF1ENST00000380817.8 linkc.2127+4C>T splice_region_variant, intron_variant Intron 18 of 40 1 NM_002972.4 ENSP00000370196.2 O95248-5

Frequencies

GnomAD3 genomes
AF:
0.0101
AC:
1536
AN:
152148
Hom.:
29
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0327
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00412
Gnomad ASJ
AF:
0.0228
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000323
Gnomad OTH
AF:
0.00718
GnomAD2 exomes
AF:
0.00358
AC:
829
AN:
231880
AF XY:
0.00301
show subpopulations
Gnomad AFR exome
AF:
0.0338
Gnomad AMR exome
AF:
0.00182
Gnomad ASJ exome
AF:
0.0255
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000539
Gnomad OTH exome
AF:
0.00319
GnomAD4 exome
AF:
0.00169
AC:
2459
AN:
1457238
Hom.:
30
Cov.:
34
AF XY:
0.00155
AC XY:
1121
AN XY:
724702
show subpopulations
African (AFR)
AF:
0.0346
AC:
1157
AN:
33400
American (AMR)
AF:
0.00221
AC:
98
AN:
44314
Ashkenazi Jewish (ASJ)
AF:
0.0253
AC:
659
AN:
26052
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39568
South Asian (SAS)
AF:
0.0000466
AC:
4
AN:
85864
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51682
Middle Eastern (MID)
AF:
0.00285
AC:
16
AN:
5614
European-Non Finnish (NFE)
AF:
0.000282
AC:
313
AN:
1110588
Other (OTH)
AF:
0.00351
AC:
211
AN:
60156
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
162
325
487
650
812
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0101
AC:
1538
AN:
152264
Hom.:
29
Cov.:
33
AF XY:
0.00986
AC XY:
734
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.0326
AC:
1356
AN:
41556
American (AMR)
AF:
0.00412
AC:
63
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0228
AC:
79
AN:
3466
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5170
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000324
AC:
22
AN:
68004
Other (OTH)
AF:
0.00711
AC:
15
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
74
148
223
297
371
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00751
Hom.:
9
Bravo
AF:
0.0117
Asia WGS
AF:
0.00346
AC:
12
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 05, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 14, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Charcot-Marie-Tooth disease type 4B3 Benign:1
Nov 07, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.14
DANN
Benign
0.50
PhyloP100
-3.1
PromoterAI
-0.034
Neutral
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0044
dbscSNV1_RF
Benign
0.32
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151027707; hg19: chr22-50900984; API